Ironwood Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,474.2% | +55.1% | +4.5% | -33.0% | -43.5% | +22.7% | |
| – | +37.5% | +64.6% | +84.3% | +17.4% | +62.3% | +13.3% | +3.6% | +5.1% | -5.7% | -3.2% | +29.8% | -2.7% | -60.8% | -36.1% | -57.9% | -5.5% | +11.1% | +27.7% | -6.5% | |
| – | – | +142.1% | +87.7% | +42.9% | +56.5% | +49.8% | +12.8% | +32.0% | -2.7% | +14.7% | +15.7% | +30.0% | -28.9% | -0.3% | -28.5% | +21.4% | +18.3% | -6.7% | -42.2% | |
| – | – | – | – | – | – | +49.9% | +16.2% | +128.0% | -7.9% | +79.7% | -120.5% | – | -13.8% | -78.4% | -1,752.0% | – | – | – | – | |
| – | +2,014.1% | -54.3% | +181.7% | -136.5% | – | – | – | – | – | – | – | – | -1,412.9% | – | – | -84.1% | +300.0% | -93.4% | +5,265.4% | |
| – | -6.1% | +765.1% | -82.4% | +325.7% | -43.8% | +44.4% | -31.4% | -63.1% | +14.4% | +2,473.6% | -96.0% | +104.7% | -16.6% | -74.4% | -85.6% | -48.7% | +100.7% | -48.0% | -76.1% | |
| – | +391.7% | -45.4% | – | -1,299.7% | – | -73.9% | -437.2% | -44.2% | -83.8% | +1,841.2% | – | -41.3% | -112.5% | -83.5% | -85.6% | -48.7% | +754,545.6% | -100.0% | -76.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +61.6% | +38.2% | -62.8% | -64.9% | +6.2% | +21.6% | -57.6% | +36.4% | -230.1% | +423.8% | -100.0% | – | – | |
| – | – | – | – | – | – | +5.8% | – | -101.3% | +530.5% | +106.8% | – | -121.4% | – | -842.6% | +0.0% | +0.0% | – | -138.3% | -100.0% | |
| – | -36.7% | -4.2% | -14.2% | +387.1% | -98.5% | +2,739.9% | +252.4% | -32.7% | +43.7% | -101.4% | – | +51.6% | -103.9% | – | -124.5% | +5,120.9% | – | -138.6% | – | |
| – | – | -67.6% | +946.7% | -240.7% | – | +15.0% | -223.9% | – | – | -210.9% | – | -33.0% | -103.3% | – | +38.6% | -86.0% | -1,668.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4,622.7% | +56.7% | +4.6% | -33.1% | -43.5% | +22.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.